Showing results (81-90 of 476) with videos related to
Sort By:
Pageof 48
Archives of Internal Medicine|May 9, 2002
Rifampin and rifabutin drug interactions: an updateChristopher K Finch, Cary R Chrisman, Anne M Baciewicz, et al.The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 9, 2004
Premenstrual asthma: emphasis on drug therapy optionsAmy M Redmond, Alan W James, Shambria Haynie Nolan, et al.American Journal of Hospital Pharmacy|May 1, 1978
Taste preference test for oral liquid theophylline preparationsW R Burleson, L J Mantlo, T H Self, et al.Therapeutic Drug Monitoring|January 1, 1984
Effect of rifampin on theophylline dispositionA B Straughn, R P Henderson, P L Lieberman, et al.Journal of Clinical Pharmacy and Therapeutics|September 14, 2017
Enzalutamide-warfarin interaction necessitating warfarin dosage adjustment: A case report of successful clinical managementJ L Parrett, A B Reaves, T H Self, et al.The Journal of Asthma : Official Journal of the Association for the Care of Asthma|May 29, 2007
Asthma treatment protocols in the emergency department: are they effective?Timothy H Self, Justin B Usery, Amanda M Howard-Thompson, et al.Journal of Neuroendocrinology|February 14, 2009
Corticotrophin-releasing factor-41 in the human and rat-utility of a highly sensitive enzyme amplified immunometric assayN G Milton, E W Hillhouse, J Q Fuller, et al.Clinical Medicine Reviews in Vascular Health|July 27, 2013
High-Risk Patients with Hypertension: Clinical Management OptionsCandace D McNaughton, Wesley H Self, Phillip D Levy, et al.Pediatrics|December 5, 2012
Reducing the blood culture contamination rate in a pediatric emergency department and subsequent cost savingsRandon T Hall, Henry J Domenico, Wesley H Self, et al.Journal of Neuroendocrinology|February 14, 2009
The effects of rat corticotrophin-releasing factor-41 Peptide fragments on bioassay and immunoassay determination of corticotrophin-releasing factor-41 levelsN G Milton, S A Nicholson, C H Self, et al.Pageof 48